Objective The aim of this work was 2-fold:(1) to evaluate current knowledge and identify key
directions in the study of sluggish cognitive tempo (SCT); and (2) to arrive at a consensus …

Social communication impairments are a core deficit in autism spectrum disorder. Social
communication deficit is also an early indicator of autism spectrum disorder and a factor in …

A systematic review of published and unpublished data on the use of long-acting
medications in ADHD and hyperkinetic disorder is reported, giving effect sizes and numbers …

Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention
deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We …

Atomoxetine (Strattera®) is a selective norepinephrine (noradrenaline) reuptake inhibitor
that is not classified as a stimulant, and is indicated for use in patients with attention-deficit …

Objective To comprehensively evaluate the efficacy and safety of atomoxetine (ATX) in
pediatric attention-deficit/hyperactivity disorder (ADHD). Method Meta-analysis of all double …

OBJECTIVE: The efficacy of atomoxetine as treatment of symptoms of attention-
deficit/hyperactivity disorder (ADHD) in patients with autism spectrum disorder (ASD) has not …

Method A review of the literature from 1980 to November, 2005 yielded 45 randomized,
placebo-controlled trials that addressed the treatment of aggression as either a primary or …

BACKGROUND:: Attention-deficit/hyperactivity disorder (ADHD) has a substantial negative
impact; however, within long-term follow-up studies, a proportion of patients do very well …

Objectives The objective of this study was to evaluate the efficacy and safety of atomoxetine
in children and adolescents. Materials and methods We searched for studies published …